Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
Reel/Frame: | 060429/0528 | |
| Pages: | 9 |
| | Recorded: | 07/07/2022 | | |
Attorney Dkt #: | 1735343 PAT1 |
Conveyance: | SECURITY INTEREST (SEE DOCUMENT FOR DETAILS). |
|
Total properties:
6
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
17397796
|
Filing Dt:
|
08/09/2021
|
Publication #:
|
|
Pub Dt:
|
04/21/2022
| | | | |
Title:
|
ULTRA-PURE AGONISTS OF GUANYLATE CYCLASE C, METHOD OF MAKING AND USING SAME
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
17495413
|
Filing Dt:
|
10/06/2021
|
Publication #:
|
|
Pub Dt:
|
03/31/2022
| | | | |
Title:
|
LIQUID ORAL DOSAGE FORMULATIONS OF METHYLNALTREXONE
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
17529818
|
Filing Dt:
|
11/18/2021
|
Publication #:
|
|
Pub Dt:
|
06/09/2022
| | | | |
Title:
|
USE OF METHYLNALTREXONE AND RIFAXIMIN FOR TREATMENT OF INCREASED GUT PERMEABILITY OR ASSOCIATED DISORDERS
|
|
|
Patent #:
|
|
Issue Dt:
|
12/12/2023
|
Application #:
|
17590027
|
Filing Dt:
|
02/01/2022
|
Publication #:
|
|
Pub Dt:
|
07/14/2022
| | | | |
Title:
|
REDUNDANT TRACES FOR FLEXIBLE CIRCUITS USED IN AN ENERGY DELIVERY DEVICE
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
17682624
|
Filing Dt:
|
02/28/2022
|
Publication #:
|
|
Pub Dt:
|
03/23/2023
| | | | |
Title:
|
METHODS OF TREATING HEPATIC ENCEPHALOPATHY
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
17687534
|
Filing Dt:
|
03/04/2022
|
Publication #:
|
|
Pub Dt:
|
09/08/2022
| | | | |
Title:
|
METHODS OF USING RIFAMYCIN SV FOR THE TREATMENT OF SICKLE CELL DISEASE
|
|
Assignee
|
|
|
745 SEVENTH AVENUE |
NEW YORK, NEW YORK 10019 |
|
Correspondence name and address
|
|
JULIA BIRGEN
|
|
1025 CONNECTICUT AVE NW, SUITE 712
|
|
COGENCY GLOBAL INC.
|
|
WASHINGTON, DC 20036
|
Search Results as of:
05/12/2024 08:41 PM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|